FDAFDA · Food and drugs·Recall number D-0364-2024
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61
Published March 13, 2024 · Recall initiated: February 20, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Contract Pharmaceuticals Limited Canada
- Distributor
- Nationwide in the U.S. and Puerto Rico
- Lot
- Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.